Position in HLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,800
-$933 QoQ
Shares Held
1,372
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#464
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Coston, McIsaac & Partners holds $48,181 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (26.6% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,800 | 1,372 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,733 | 1,372 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $13,870 | 1,372 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $13,338 | 1,487 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $15,420 | 1,487 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $15,301 | 1,487 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,185 | 1,487 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $15,732 | 1,487 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $12,282 | 1,487 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $12,624 | 1,487 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $12,238 | 1,487 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $12,386 | 1,487 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,461 | 1,487 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $12,104 | 1,487 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $11,896 | 1,487 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,055 | 1,487 | Shares | Sole | 2022-10-31 | |
| No filing history on record for this holder in this stock. | ||||||